AFT Pharmaceuticals (NZX.AFT, ASX.AFP) announces it expects to book a one-off non-cash gain of $9.8 million following its previously-announced acquisition of full control of its Pascomer assets
AbbVie (NYSE: ABBV) New Zealand welcomes PHARMAC’s announcement that patients with chronic lymphocytic leukaemia (CLL) whose cancer has relapsed within 36 months of previous treatment will now have funded access to VENCLEXTA® (venetoclax) in combination with rituximab, from 1 December 2019
This November, Diabetes NZ is teaming up with key organisations to help find the 100,000 Kiwis with undiagnosed type 2 diabetes. With the theme It’s About Time, Diabetes Action Month runs for all of November
The Pharmacy Guild of New Zealand (the Guild) welcomes the Government’s announcement that community pharmacists will now be able to deliver the MMR vaccine
Associate Minister of Health Julie Anne Genter says trained pharmacist vaccinators in approximately 450 pharmacies across New Zealand will soon be able to deliver MMR vaccinations to people aged 16 and over, as the latest step in the Government’s plan to stop the measles outbreak and improve the immunity of New Zealanders
Source
Media release from associate health minister Julie Anne Genter
The Community Pharmacy Leaders Forum (CPLF), a collaboration of pharmacy organisation leaders with a focus on New Zealand community pharmacies, had a productive meeting this week focused on developing a unified response to key issues facing community pharmacy
Medication errors are among the most common incidents reported in hospitals, often occurring at hospital admission, with a new study led by Monash University and Alfred Health researchers evaluating a collaborative model to reduce medication errors and length of hospital stay
An Australian-Fijian medicinal kava company, today announced the signing of a Memorandum of Understanding with Green Cross Healthto market and sell Fiji Kava products across its significant nation-wide pharmacy network in New Zealand
Academic pharmacist Nataly Martini provides key information on Helicobacter pylori pathophysiology, diagnosis and evidence-based treatment strategies to enhance patient outcomes